Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury

Outer membrane vesicles (OMVs) are important tools in bacterial virulence but their role in the pathogenesis of infections caused by enterohemorrhagic Escherichia coli (EHEC) O157, the leading cause of life-threatening hemolytic uremic syndrome, is poorly understood. Using proteomics, electron and confocal laser scanning microscopy, immunoblotting, and bioassays, we investigated OMVs secreted by EHEC O157 clinical isolates for virulence factors cargoes, interactions with pathogenetically relevant human cells, and mechanisms of cell injury. We demonstrate that O157 OMVs carry a cocktail of key virulence factors of EHEC O157 including Shiga toxin 2a (Stx2a), cytolethal distending toxin V (CdtV), EHEC hemolysin, and flagellin. The toxins are internalized by cells via dynamin-dependent endocytosis of OMVs and differentially separate from vesicles during intracellular trafficking. Stx2a and CdtV-B, the DNase-like CdtV subunit, separate from OMVs in early endosomes. Stx2a is trafficked, in association with its receptor globotriaosylceramide within detergent-resistant membranes, to the Golgi complex and the endoplasmic reticulum from where the catalytic Stx2a A1 fragment is translocated to the cytosol. CdtV-B is, after its retrograde transport to the endoplasmic reticulum, translocated to the nucleus to reach DNA. CdtV-A and CdtV-C subunits remain OMV-associated and are sorted with OMVs to lysosomes. EHEC hemolysin separates from OMVs in lysosomes and targets mitochondria. The OMV-delivered CdtV-B causes cellular DNA damage, which activates DNA damage responses leading to G2 cell cycle arrest. The arrested cells ultimately die of apoptosis induced by Stx2a and CdtV via caspase-9 activation. By demonstrating that naturally secreted EHEC O157 OMVs carry and deliver into cells a cocktail of biologically active virulence factors, thereby causing cell death, and by performing first comprehensive analysis of intracellular trafficking of OMVs and OMV-delivered virulence factors, we provide new insights into the pathogenesis of EHEC O157 infections. Our data have implications for considering O157 OMVs as vaccine candidates.

[1]  J. Badia,et al.  Outer Membrane Vesicles from the Probiotic Escherichia coli Nissle 1917 and the Commensal ECOR12 Enter Intestinal Epithelial Cells via Clathrin-Dependent Endocytosis and Elicit Differential Effects on DNA Damage , 2016, PloS one.

[2]  J. Badia,et al.  Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains , 2016, Front. Microbiol..

[3]  T. Frisan.  Bacterial genotoxins: The long journey to the nucleus of mammalian cells. , 2016, Biochimica et biophysica acta.

[4]  P. Kohl,et al.  A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria , 2016, Nature Communications.

[5]  S. Blanke,et al.  Distinct Roles for CdtA and CdtC during Intoxication by Cytolethal Distending Toxins , 2015, PloS one.

[6]  Björn Kemper,et al.  Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain , 2015, Scientific Reports.

[7]  F. Taieb,et al.  Cytolethal distending toxin A, B and C subunit proteins are necessary for the genotoxic effect of Escherichia coli CDT-V. , 2015, Acta veterinaria Hungarica.

[8]  M. Mörgelin,et al.  A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles , 2015, PLoS pathogens.

[9]  J. Dirienzo.  Uptake and Processing of the Cytolethal Distending Toxin by Mammalian Cells , 2014, Toxins.

[10]  Angela R Melton-Celsa,et al.  Shiga Toxin (Stx) Classification, Structure, and Function , 2014, Microbiology spectrum.

[11]  S. Wai,et al.  Aggregatibacter actinomycetemcomitans Outer Membrane Vesicles Are Internalized in Human Host Cells and Trigger NOD1- and NOD2-Dependent NF-κB Activation , 2014, Infection and Immunity.

[12]  R. Damoiseaux,et al.  Cytolethal Distending Toxins Require Components of the ER-Associated Degradation Pathway for Host Cell Entry , 2014, PLoS pathogens.

[13]  G. Mirey,et al.  The Cytolethal Distending Toxin Effects on Mammalian Cells: A DNA Damage Perspective , 2014, Cells.

[14]  T. Frisan,et al.  Salmonella enterica delivers its genotoxin through outer membrane vesicles secreted from infected cells , 2013, Cellular microbiology.

[15]  A. Mellmann,et al.  Enterohemorrhagic Escherichia coli Hemolysin Employs Outer Membrane Vesicles to Target Mitochondria and Cause Endothelial and Epithelial Apoptosis , 2013, PLoS pathogens.

[16]  R. Mandrell,et al.  A Polyclonal Antibody Based Immunoassay Detects Seven Subtypes of Shiga Toxin 2 Produced by Escherichia coli in Human and Environmental Samples , 2013, PloS one.

[17]  K. Sandvig,et al.  Retrograde transport of protein toxins through the Golgi apparatus , 2013, Histochemistry and Cell Biology.

[18]  B. Wilson,et al.  Cellular Interactions of the Cytolethal Distending Toxins from Escherichia coli and Haemophilus ducreyi* , 2013, The Journal of Biological Chemistry.

[19]  Hui Sun,et al.  Enterohemorrhagic Escherichia coli Specific Enterohemolysin Induced IL-1β in Human Macrophages and EHEC-Induced IL-1β Required Activation of NLRP3 Inflammasome , 2012, PloS one.

[20]  Michael L. Reno,et al.  Bacterial toxin modulation of the eukaryotic cell cycle: are all cytolethal distending toxins created equally? , 2012, Front. Cell. Inf. Microbio..

[21]  Lassi Paavolainen,et al.  BioImageXD: an open, general-purpose and high-throughput image-processing platform , 2012, Nature Methods.

[22]  J. Korostoff,et al.  Localization of Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Subunits during Intoxication of Live Cells , 2012, Infection and Immunity.

[23]  Sang-Rae Lee,et al.  Mouse model for hemolytic uremic syndrome induced by outer membrane vesicles of Escherichia coli O157:H7. , 2011, FEMS immunology and medical microbiology.

[24]  S. Wai,et al.  Perinuclear Localization of Internalized Outer Membrane Vesicles Carrying Active Cytolethal Distending Toxin from Aggregatibacter actinomycetemcomitans , 2011, Infection and Immunity.

[25]  R. Langer,et al.  Tumor-Specific Targeting of Pancreatic Cancer with Shiga Toxin B-Subunit , 2011, Molecular Cancer Therapeutics.

[26]  S. Bloom,et al.  Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. , 2011, Microbiology.

[27]  A. Friedrich,et al.  Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains[S] , 2011, Journal of Lipid Research.

[28]  T. Frisan,et al.  The Biology of the Cytolethal Distending Toxins , 2011, Toxins.

[29]  G. Bally,et al.  Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells , 2010, Thrombosis and Haemostasis.

[30]  B. Sarg,et al.  EspP, a Serine Protease of Enterohemorrhagic Escherichia coli, Impairs Complement Activation by Cleaving Complement Factors C3/C3b and C5 , 2010, Infection and Immunity.

[31]  B. Binnington,et al.  Globotriaosyl ceramide receptor function – Where membrane structure and pathology intersect , 2010, FEBS letters.

[32]  A. Kane,et al.  Shiga Toxin 2 and Flagellin from Shiga-Toxigenic Escherichia coli Superinduce Interleukin-8 through Synergistic Effects on Host Stress-Activated Protein Kinase Activation , 2010, Infection and Immunity.

[33]  M. Morigi,et al.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction , 2010, Pediatric Nephrology.

[34]  G. Oakley,et al.  Helicobacter hepaticus Cytolethal Distending Toxin Causes Cell Death in Intestinal Epithelial Cells via Mitochondrial Apoptotic Pathway , 2010, Helicobacter.

[35]  M. Kuehn,et al.  Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles , 2010, Microbiology and Molecular Biology Reviews.

[36]  C. Whitchurch,et al.  Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells , 2010, Cellular microbiology.

[37]  L. Johannes,et al.  Shiga toxins — from cell biology to biomedical applications , 2010, Nature Reviews Microbiology.

[38]  Bruce A. Stanton,et al.  Long-Distance Delivery of Bacterial Virulence Factors by Pseudomonas aeruginosa Outer Membrane Vesicles , 2009, PLoS pathogens.

[39]  A. Mellmann,et al.  Subtypes of the Plasmid-Encoded Serine Protease EspP in Shiga Toxin-Producing Escherichia coli: Distribution, Secretion, and Proteolytic Activity , 2007, Applied and Environmental Microbiology.

[40]  C. Lingwood,et al.  Membrane cytosolic translocation of verotoxin A1 subunit in target cells. , 2007, Microbiology.

[41]  A. Friedrich,et al.  Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. , 2007, Microbes and infection.

[42]  P. Sestili,et al.  Molecular Damage and Induction of Proinflammatory Cytokines in Human Endothelial Cells Exposed to Shiga Toxin 1, Shiga Toxin 2, and α-Sarcin , 2007, Infection and Immunity.

[43]  L. Johannes,et al.  Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells , 2006, The FEBS journal.

[44]  T. Kirchhausen,et al.  Dynasore, a cell-permeable inhibitor of dynamin. , 2006, Developmental cell.

[45]  A. Friedrich,et al.  Cytolethal Distending Toxin in Escherichia coli O157:H7: Spectrum of Conservation, Structure, and Endothelial Toxicity , 2006, Journal of Clinical Microbiology.

[46]  Jan Löwe,et al.  RF cloning: a restriction-free method for inserting target genes into plasmids. , 2006, Journal of biochemical and biophysical methods.

[47]  R. Polanowska-Grabowska,et al.  Shiga Toxin 2 and Lipopolysaccharide Induce Human Microvascular Endothelial Cells To Release Chemokines and Factors That Stimulate Platelet Function , 2005, Infection and Immunity.

[48]  H. Karch,et al.  Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.

[49]  H. Ploegh,et al.  Cellular internalization of cytolethal distending toxin: a new end to a known pathway , 2005, Cellular microbiology.

[50]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[51]  H. Karch,et al.  Cytolethal Distending Toxin from Shiga Toxin-Producing Escherichia coli O157 Causes Irreversible G2/M Arrest, Inhibition of Proliferation, and Death of Human Endothelial Cells , 2005, Infection and Immunity.

[52]  M. Reedy,et al.  Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells , 2004, The EMBO journal.

[53]  Steven F Dowdy,et al.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.

[54]  H. Karch,et al.  Cytolethal Distending Toxin Gene Cluster in Enterohemorrhagic Escherichiacoli O157:H− and O157:H7: Characterization and Evolutionary Considerations , 2003, Infection and Immunity.

[55]  David G. E. Smith,et al.  Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity , 2003, Cellular microbiology.

[56]  Mark von Zastrow,et al.  Signal transduction and endocytosis: close encounters of many kinds , 2002, Nature Reviews Molecular Cell Biology.

[57]  R. Lloubès,et al.  Pal Lipoprotein of Escherichia coli Plays a Major Role in Outer Membrane Integrity , 2002, Journal of bacteriology.

[58]  J. Salamero,et al.  Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. , 2001, Molecular biology of the cell.

[59]  J. Galán,et al.  CdtA, CdtB, and CdtC Form a Tripartite Complex That Is Required for Cytolethal Distending Toxin Activity , 2001, Infection and Immunity.

[60]  K. Yokoyama,et al.  Production of shiga toxin by Escherichia coli measured with reference to the membrane vesicle-associated toxins. , 2000, FEMS microbiology letters.

[61]  J. Galán,et al.  A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. , 2000, Science.

[62]  H. Doi,et al.  Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between bcl-2 and tissue failure by E. coli O157:H7. , 2000, Genes & development.

[63]  J. Smith,et al.  Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. , 2000, The Journal of clinical investigation.

[64]  G. Chen,et al.  Restriction site-free insertion of PCR products directionally into vectors. , 2000, BioTechniques.

[65]  Glynis L. Kolling,et al.  Export of Virulence Genes and Shiga Toxin by Membrane Vesicles of Escherichia coli O157:H7 , 1999, Applied and Environmental Microbiology.

[66]  J. Salamero,et al.  Direct Pathway from Early/Recycling Endosomes to the Golgi Apparatus Revealed through the Study of Shiga Toxin B-fragment Transport , 1998, The Journal of cell biology.

[67]  P. Orlandi,et al.  Filipin-dependent Inhibition of Cholera Toxin: Evidence for Toxin Internalization and Activation through Caveolae-like Domains , 1998, The Journal of cell biology.

[68]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[69]  É. Oswald,et al.  Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation , 1997, Infection and immunity.

[70]  F. Gilles,et al.  Selective expression of adhesion molecules on human brain microvascular endothelial cells , 1997, Journal of Neuroimmunology.

[71]  H. Karch,et al.  EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V , 1997, Molecular microbiology.

[72]  S. Grinstein,et al.  Dynamic measurement of the pH of the Golgi complex in living cells using retrograde transport of the verotoxin receptor , 1996, The Journal of cell biology.

[73]  G. Warren,et al.  Characterization of a cis-Golgi matrix protein, GM130 , 1995, The Journal of cell biology.

[74]  K. Sandvig,et al.  Furin-induced Cleavage and Activation of Shiga Toxin (*) , 1995, The Journal of Biological Chemistry.

[75]  L. Beutin,et al.  Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933 , 1995, Infection and immunity.

[76]  R. G. Anderson,et al.  Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation , 1993, The Journal of cell biology.

[77]  J. Heesemann,et al.  Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H- , 1993, Journal of clinical microbiology.

[78]  Kristian Prydz,et al.  Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum , 1992, Nature.

[79]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[80]  R. Holmes,et al.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities , 1986, Infection and immunity.

[81]  K. Tokuyasu.  Immunochemistry on ultrathin frozen sections , 1980, The Histochemical Journal.

[82]  M D Flanagan,et al.  Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. , 1980, The Journal of biological chemistry.

[83]  B. Berne,et al.  Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics , 1976 .

[84]  Dennis E. Koppel,et al.  Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants , 1972 .

[85]  V. L. Tesh.  The induction of apoptosis by Shiga toxins and ricin. , 2012, Current topics in microbiology and immunology.

[86]  K. Sandvig,et al.  Shiga toxins. , 2012, Toxicon : official journal of the International Society on Toxinology.

[87]  A. Friedrich,et al.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.

[88]  I. Ørskov,et al.  2 Serotyping of Escherichia coli , 1984 .

[89]  L. Johannes,et al.  Article Title: the Association of Shiga-like Toxin with Detergent-resistant Membranes Is Modulated by Glucosylceramide and Is an Essential Requirement in the Endoplasmic Reticulum for a Cytotoxic Effect the Association of Shiga-like Toxin with Detergent- Resistant Membranes Is Modulated by Glucosylc , 2022 .